New strategies for combination vaccines based on the extended recombinant bacterial ghost system.
about
Bacterial ghosts as adjuvants: mechanisms and potential.Enhancement of bacteriolysis of shuffled phage PhiX174 gene E.Hybrid biosynthetic gene therapy vector development and dual engineering capacity.Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate.Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery.Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors.Construction of a Salmonella Gallinarum ghost as a novel inactivated vaccine candidate and its protective efficacy against fowl typhoid in chickens.Delivery of Chlamydia vaccines.Bacterial ghosts as a novel advanced targeting system for drug and DNA delivery.Generation of Salmonella ghost cells expressing fimbrial antigens of enterotoxigenic Escherichia coli and evaluation of their antigenicity in a murine modelSelf-adjuvanting bacterial vectors expressing pre-erythrocytic antigens induce sterile protection against malariaExploiting cholera vaccines as a versatile antigen delivery platformProtective efficacy and immune responses by homologous prime-booster immunizations of a novel inactivated Salmonella Gallinarum vaccine candidate.Rectal single dose immunization of mice with Escherichia coli O157:H7 bacterial ghosts induces efficient humoral and cellular immune responses and protects against the lethal heterologous challengeImmunolocalization and challenge studies using a recombinant Vibrio cholerae ghost expressing Trypanosoma brucei Ca(2+) ATPase (TBCA2) antigen.Harnessing the potential of bacterial ghost for the effective delivery of drugs and biotherapeutics.Improved lysis efficiency and immunogenicity of Salmonella ghosts mediated by co-expression of λ phage holin-endolysin and ɸX174 gene E.Towards a Chlamydia trachomatis vaccine: how close are we?Cell-based drug-delivery platforms.Phage lytic proteins: biotechnological applications beyond clinical antimicrobials.A novel method to generate Salmonella Typhi Ty21a ghosts exploiting the λ phage holin-endolysin system.The study of H. pylori putative candidate factors for single- and multi-component vaccine development.Online monitoring of Escherichia coli ghost production.Escherichia coli ghost production by expression of lysis gene E and Staphylococcal nuclease.Evaluation of immunogenicity and protective efficacy of adjuvanted Salmonella Typhimurium ghost vaccine against salmonellosis in chickens.A novel one-step expression and immobilization method for the production of biocatalytic preparationsDiseases originate and terminate by genes: unraveling nonviral gene delivery.The use of bacterial minicells to transfer plasmid DNA to eukaryotic cells.Purification and functional characterization of phiX174 lysis protein E.Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge.Salmonella ghosts expressing enterotoxigenic Escherichia coli k88ab, k88ac, k99, and fasa fimbrial antigens induce robust immune responses in a mouse model.
P2860
Q33830398-1910E4C1-4E3F-460E-9F67-67E3A360E6B3Q33891504-B68DB328-01B5-4002-A96B-2202B3357881Q34120110-D9769F0E-8601-436E-9BA0-48090E20FE9DQ34883543-81B0BEDD-3EBF-4DF9-98B6-78D5465DCBA1Q35193536-A95D8623-2BBA-456D-807E-937344B14214Q35987800-B8BA6B66-1210-4B76-A133-0D91758189F9Q36146258-5BC7E89B-E963-43F9-A8A1-0072DC8D32D3Q36316798-291F4E0B-4056-4537-82B9-BECB9A89B037Q36349667-60CECB06-4569-441A-9A0B-55CC75BF61C6Q36390119-6F15C74D-BB81-406E-9ED4-A173BEFADBA9Q36981626-1443AED4-6370-4901-B824-2272AFBE56B1Q37002887-E035BD53-2C19-49A0-8094-F6C9E6743A3BQ37143644-8BA37885-D4F2-43FA-AA76-CC1DAFF055C7Q37274702-3D02BCC7-9C45-4910-99C4-F053188AF36AQ37450423-4AD9F645-D3A7-46A2-8E8C-8E9A63CD9EB8Q37621279-23D3D56F-4DF2-4680-9BBD-3227DCDC1D40Q37717154-9930FD8E-D8ED-4A32-8B60-AF8B8638D39CQ37820669-BC7F2655-D5CE-4F87-8DD0-87978EC7D85BQ38029631-89D973AF-C545-4504-8D5F-D87079845267Q38325227-3051CDC5-E506-4CD6-BBA9-44E297A991DDQ38715456-27F5EA85-7846-495F-B678-BE25F5356135Q39350897-99216F2F-F57F-4930-A280-AEED337B638FQ39743049-871B88EC-C988-4287-B86D-FF2026BD222AQ39913745-605BB032-611B-4088-AD5A-2742BF95DDACQ40846782-A7750953-498F-4287-AE21-B5B6D0396AC7Q41118283-AB74A5BE-221C-4127-B34B-B558C929BEBDQ41197665-E1664F7A-A148-4409-B47F-5F0D19B61F38Q41452234-41284A9E-338A-4442-AFC1-CE04B49021D4Q41852676-539B1DD5-4A03-40B1-9B53-5A320D1760A3Q42138165-4EDEF5B8-1B68-4A4A-835C-767F29C70F3BQ42174414-143C242A-121B-4E85-A0AE-7E43E9CA55F8
P2860
New strategies for combination vaccines based on the extended recombinant bacterial ghost system.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
New strategies for combination ...... binant bacterial ghost system.
@ast
New strategies for combination ...... binant bacterial ghost system.
@en
New strategies for combination ...... binant bacterial ghost system.
@nl
type
label
New strategies for combination ...... binant bacterial ghost system.
@ast
New strategies for combination ...... binant bacterial ghost system.
@en
New strategies for combination ...... binant bacterial ghost system.
@nl
prefLabel
New strategies for combination ...... binant bacterial ghost system.
@ast
New strategies for combination ...... binant bacterial ghost system.
@en
New strategies for combination ...... binant bacterial ghost system.
@nl
P2093
P1433
P1476
New strategies for combination ...... binant bacterial ghost system.
@en
P2093
Fürst-Ladani S
Haidinger W
Haslberger A
Jechlinger W
Katinger A
P304
P356
10.1016/S0264-410X(98)00423-X
P407
P577
1999-03-01T00:00:00Z